PathWhiz

Pathway Description

Certoparin Action Pathway

Homo sapiens

Drug Action Pathway

Certoparin is a heparin with a low molecular weight (LMWH), it prevents and treats venous thromboembolism. Certoparin can interact with herbs and supplements, it is best to avoid those with anticoagulant and antiplatelet activity such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba.

References

Certoparin Pathway References

Donadini MP, Ageno W, Guasti L, Squizzato A: Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies. Expert Opin Drug Metab Toxicol. 2013 Jul;9(7):901-9. doi: 10.1517/17425255.2013.794787. Epub 2013 Apr 27.

Pubmed: 23621639

Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM: Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin. Semin Thromb Hemost. 2001 Oct;27(5):513-8. doi: 10.1055/s-2001-17953.

Pubmed: 11668421

Adolf J, Fritsche HM, Haas S, Hennig FF, Horbach T, Kastl S, Koppenhagen K, Michaelis HC, Rhamanzadeh R, Summa W, Wagner W, Weber U, Wolf H: Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group. Int Angiol. 1999 Jun;18(2):122-6.

Pubmed: 10424367

Highlighted elements will appear in red.

Highlight Compounds

	Calcium
	Certoparin

Highlight Proteins

	Antithrombin-III
	Coagulation factor X
	Fibrinogen alpha chain
	Fibrinogen beta chain
	Fibrinogen gamma chain
	Thrombin

Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.

Visualize Compound Data